Copyright
©The Author(s) 2015.
World J Gastroenterol. Nov 14, 2015; 21(42): 12022-12041
Published online Nov 14, 2015. doi: 10.3748/wjg.v21.i42.12022
Published online Nov 14, 2015. doi: 10.3748/wjg.v21.i42.12022
Figure 1 Schematic representation of various treatment strategies for hepatocellular carcinoma at different stages according to the Barcelona Clinic Liver Cancer algorithm.
RFA: Radiofrequency ablation, PEI: Percutaneous ethanol injection; TACE: Trans catheter arterial chemoembolization.
Figure 2 Different methods of targeted delivery of nanoparticles by passive or active mechanism.
EPR: Enhanced permeation and retention.
Figure 3 Schematic representation of the biotinylated cyclic Arg-Gly-Asp nanoparticles loaded with doxorubicin.
PEG: Polyethylene glycol; RGD: Arg-Gly-Asp.
- Citation: Varshosaz J, Farzan M. Nanoparticles for targeted delivery of therapeutics and small interfering RNAs in hepatocellular carcinoma. World J Gastroenterol 2015; 21(42): 12022-12041
- URL: https://www.wjgnet.com/1007-9327/full/v21/i42/12022.htm
- DOI: https://dx.doi.org/10.3748/wjg.v21.i42.12022